CAPPED BONUSZERTIFIKAT - MEDTRONIC Share Price

Certificat

DE000PC5JV40

Market Closed - Börse Stuttgart 08:03:37 08/05/2024 BST
62.29 EUR +0.27% Intraday chart for CAPPED BONUSZERTIFIKAT - MEDTRONIC
Current month+0.16%
1 month+1.09%
Date Price Change Volume
08/05/24 62.29 +0.27% 0
07/05/24 62.12 +0.06% 0
06/05/24 62.08 -0.08% 0
03/05/24 62.13 -0.03% 0
02/05/24 62.15 -0.06% 0

Delayed Quote Börse Stuttgart

Last update May 08, 2024 at 08:03 am

More quotes

Static data

Product typeCertificados de Bonus y Protección Parcial
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5JV4
ISINDE000PC5JV40
Date issued 23/02/2024
Strike 70 $
Maturity 20/12/2024 (226 Days)
Parity 1 : 1
Emission price 60.64
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 62.38
Lowest since issue 60.68
Spread 0.1
Spread %0.16%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
81.55 USD
Average target price
94.77 USD
Spread / Average Target
+16.22%
Consensus